Scientific Publications by FDA Staff
Expert Opin Drug Metab Toxicol 2013 Jun;9(6):713-24
Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease.
Pogribny IP, Beland FA
Introduction: The pathogenesis of diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) is complex, and the underlying molecular mechanisms are only partially understood. Areas covered: This review summarizes current knowledge of the role of microRNAs (miRNAs) in the regulation of drug absorption, distribution, metabolism, and excretion genes in the pathogenesis of diabetes and NAFLD. The literature search was performed using the PubMed database (up to February 2013). Expert opinion: miRNAs play a fundamental role in diabetes and NAFLD. This review focuses on the dysregulation of miRNAs involved in the regulation of drug metabolism and disposition in the pathogenesis of these metabolic syndromes. The evidence presented indicates that better understanding of the underlying molecular mechanisms associated with dysregulation of miRNAs controlling the cellular drug metabolizing system is of great importance not only from a scientific, but also from a clinical perspective. More importantly, an association between these metabolic disorders and miRNA dysregulation suggests that correcting miRNA expression by either their up-regulation or inhibition holds a promise for treating these metabolic syndrome and alleviating disease progression.
|Category: Journal Article, Review|
|PubMed ID: #23565851|
|Includes FDA Authors from Scientific Area(s): Toxicological Research|
|Entry Created: 2013-04-10||Entry Last Modified: 2013-12-16|